2025/03/24
Press Release
March 21, 2025, a researching group led by Mr. Okano Hideyuki (Director, Keio University Research Center for Regenerative Medicine) and Mr. Masaya Nakamura (Professor, Keio University School of Medicine & Chairperson, Steering Committee for Cluster for Regenerative Medicine in Tonomachi Haneda), has completed follow-up observations and collection of evaluation data for all 4 planned cases on “Regenerative Medicine Using iPS Cell-Derived Neural Stem/Progenitor Cells to Treat Subacute Spinal Cord Injuries”.
Domestic and international newspapers and magazines, along with Nature’s news section, featured the results.
【Domestic】
NHK：iPS細胞使った脊髄損傷治療で機能改善 慶応大学などのグループ
Nikkei Inc.：慶応大のiPS脊髄損傷治療、安全性確認 症状改善も
The Yomiuri Shimbun：ｉＰＳ細胞移植後に２人の運動機能が改善、脊髄損傷患者が自分で食事をとれるように…世界初
Japan Daily News – The Mainichi：iPS細胞で脊髄損傷治療「2人の重症度が改善」 慶応大など発表
Asahi Weekly：脊髄損傷の患者にiPS由来の細胞移植、4人中2人で一部回復 慶大
YAHOO! JAPAN：世界初 iPS細胞用いた脊髄損傷治療 臨床研究の成果発表
Keio University：「亜急性期脊髄損傷に対するiPS細胞由来神経前駆細胞を用いた再生医療」の臨床研究について（経過観察の終了）
Keio University Regenerative Medicine Research Center HP
【Internationally】
Nature NEWS： Paralysed man stands again after receiving ‘reprogrammed’ stem cells
